Intravitreal Vascular Endothelial Growth Factor Inhibitor Use and Renal Function Decline in Patients with Diabetic Retinopathy

Adverse renal effects of systemic vascular endothelial growth factor (VEGF) inhibitor treatment are well documented. We aimed to identify associations between intravitreal VEGF inhibitor use and renal function decline in patients with diabetic retinopathy. We included 625 patients with diabetic reti...

Descripción completa

Detalles Bibliográficos
Autores principales: Ou, Shih-Hsiang, Yin, Chun-Hao, Chung, Tung-Ling, Chen, Hsin-Yu, Chen, Chien-Liang, Chen, Jin-Shuen, Lee, Po-Tsang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657653/
https://www.ncbi.nlm.nih.gov/pubmed/36361175
http://dx.doi.org/10.3390/ijerph192114298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657653/
https://www.ncbi.nlm.nih.gov/pubmed/36361175
http://dx.doi.org/10.3390/ijerph192114298

Ejemplares similares